XIFIN Named Top-Tier Software Vendor by APPS RUN THE WORLD in the APPS and CLOUD TOP 500 Market Report

XIFIN Strengths, Domain Expertise, and Key Differentiators

XiFin's key differentiators lie in its comprehensive product portfolio and domain expertise. The company's cloud-based workflow application and health economics optimization platform enable seamless connectivity across the healthcare ecosystem, driving better business and patient outcomes. Additionally, XiFin's recent acquisitions, such as PathCentral, have enhanced its capabilities in pathology and molecular diagnostics, further strengthening its competitive advantage.

XIFIN Recent Developments

In January 2024, OmniSYS, XiFin's pharmacy division, announced the success of its CareALERTS™ program in increasing companion pneumococcal immunizations by 28% among participating pharmacies. This initiative not only enhances patient care but also creates a valuable revenue stream for pharmacies, contributing to lower healthcare costs nationally.

In December 2023, XiFin launched the Payor Rate Transparency Monitor, providing diagnostic providers and laboratories with insights into managed care reimbursement rates. These initiatives reflect XiFin's commitment to leveraging technology for better healthcare outcomes.

In August 2023, XiFin has launched an enhanced Lab Volume Index (LVI) that provides deeper insights into post-pandemic diagnostic testing trends. Derived from claims transaction data within the XiFin RPM platform, the LVI shows that while COVID testing has declined, overall molecular testing has steadily grown, particularly in women's health, notably prenatal testing. The new LVI features expanded functionality and allows users to compare testing volumes over time, offering valuable insights into the evolving landscape of diagnostic testing.

XiFin's revenue growth and profit data are equally impressive, with a 37% CAGR from 2019 to 2022. Strategic acquisitions, including Computerized Management Services and OmniSYS, have contributed to this growth, solidifying XiFin's position as a leader in healthcare IT.

XIFIN Mergers and Acquisitions (M&A) Activities

In December 2021, XIFIN announced the strategic acquisition of OmniSYS, a prominent player in the retail pharmacy industry. This acquisition expands XIFIN's portfolio to support retail pharmacies transitioning to a clinical services model, facilitating closer relationships between pharmacies and diagnostic providers. The move aligns with the industry trend of pharmacies expanding their role as providers of primary and preventative care, driven by factors such as the COVID-19 pandemic and increasing consumerization of healthcare. Through this acquisition, XIFIN aims to enhance connectivity between consumers, pharmacies, payors, and laboratories, ultimately optimizing personalized medicine and care coordination.

In July 2021, XIFIN acquired Computerized Management Services (CMS), Inc. Considered a premier solution within the radiology market, CMS provides a comprehensive suite of outsourced financial services focused on maximizing client revenue and cash flow. Its services leverage effective technology systems, integrations, analytics, and services, including RCM, strategic consulting, credentialing, and coding.

XIFIN Customers in ARTW Customer Database

Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying XIFIN applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of XIFIN and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified XIFIN platform, customers.

XIFIN Key Enterprise and Cloud Applications

XIFIN platform,

XIFIN Revenues, $M:

XIFIN Revenue Breakdown By Type, $M:

XIFIN Enterprise Applications Revenues By Functional Markets, $M:

XIFIN Enterprise Applications Revenues By Verticals, $M:

XIFIN Revenues By Region, $M

XIFIN Direct vs Indirect sales

XIFIN Customers - Breakdown by Geo, Size, Vertical and Product

List of Verified XIFIN Customers

No. of XIFIN Customers: x

No. of XIFIN Enterprise Applications Customers: x

No. of XIFIN Cloud Customers: x

No. of XIFIN Cloud Subscribers: x

XiFin's customer base includes some of the largest public laboratories, integrated delivery networks, and retail pharmacies in the United States. The company's solutions are trusted by Northwell Health Labs, MercyOne, Perry Health, Sonora Quest Laboratories, Interpace Biosciences, and other.

XIFIN Market Opportunities, M&A and Geo Expansions

XiFin has significant market opportunities both horizontally and vertically. The company can further expand its presence in new regions and industries while capitalizing on the growing demand for cloud-based healthcare solutions. With a focus on radiology, pharmacy, and hospital services, XiFin is well-positioned to lead the transformation of healthcare delivery through its advanced technology solutions.

XiFin's recent appointments of Erik Sallee as CFO, John Kelly as CIO, and Harley Ross as Chief Commercial Officer underscore its commitment to growth and innovation. With a focus on market expansion and technological advancement, XiFin is poised to shape the future of healthcare IT.

XIFIN Risks and Challenges

XiFin faces risks related to integration challenges following its acquisitions and potential market competition. The company's ability to scale its customer count and effectively manage these risks will be crucial for its long-term success.

XIFIN Ecosystem, Partners, Resellers and SI

XiFin's ecosystem includes technology integrations and partnerships with leading companies such as WDOLBEY, Consensus, CONCORD, Clover, Braintreer, Fabric, ELLKAY and others. These partnerships enhance XiFin's offerings and contribute to the network effects of system integrators and value-added resellers.

XIFIN Cloud Infrastructure Insights

Subscribe to read more about:

• XIFIN Public Cloud and Infrastructure (IaaS)
• XIFIN Platform (PaaS)
• XIFIN Application Delivery
• XIFIN Private Cloud and Data Centers

Research Methodology

Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.

Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).

For additional information on our methodologies, here's the link: